Multiple-dose study investigating the pharmacokinetics, pharmacodynamics and safety of tolvaptan in healthy Japanese male volunteers
Latest Information Update: 11 Jun 2012
Price :
$35 *
At a glance
- Drugs Tolvaptan (Primary)
- Indications Cardiac oedema
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Otsuka Pharmaceutical
- 11 Jun 2012 New trial record